Target intelligence / Profile preview

E3 ubiquitin-protein ligase ZNRF1 (ZNRF1)

Target
ZNRF1
Molecular classification
Enzyme, E3 ubiquitin ligase, RING-finger protein
01

Overview

E3 ubiquitin-protein ligase ZNRF1 is an enzyme containing both a zinc finger and a RING finger motif, functioning as a RING-type E3 ubiquitin ligase highly expressed in the nervous system and other tissues[1][5][7]. ZNRF1 catalyzes the transfer of ubiquitin to substrate proteins, marking them for degradation by the proteasome or modulating their signaling functions. In neurons, it localizes primarily to synaptic vesicle membranes and participates in regulating neuronal transmission, synaptic plasticity, and neurite outgrowth[1][2]. ZNRF1 is implicated in processes such as neural development, axonal degeneration, and the neuroimmune response, partly by modulating signaling molecules like AKT1, EGFR, and caveolin-1[5]. It controls inflammation by regulating degradation of caveolin-1 and modulates Toll-like receptor 4 (TLR4)-mediated immune signaling; loss or dysfunction of ZNRF1 can suppress pro-inflammatory cytokine production and protect against sepsis in animal models[3][5]. ZNRF1 may also play a role in Schwann cell differentiation and is upregulated following nerve injury, suggesting a role in nerve regeneration and degeneration[1][5]. No clinical drugs officially target ZNRF1, but its activity affects pathways relevant to neurodegeneration, inflammation, and cellular homeostasis.

Other names
ZNRF1zinc and ring finger 1NIN283E3 ubiquitin-protein ligase ZNRF1nerve injury-induced gene 283 proteinRING-type E3 ubiquitin transferase ZNRF1zinc/RING finger protein 1nerve injury gene 283FLJ14846DKFZp434E229
02

Mechanism of action

Ubiquitination of substrate proteins leading to their proteasomal degradation or altered cellular signaling

03

Biological functions

Ubiquitin-mediated protein modificationNeuronal transmission and synaptic plasticityCell differentiation, especially neural and Schwann cellsRegulation of receptor recyclingRegulation of inflammation
04

Disease associations

Neurodegenerative diseaseInflammationPotential roles in cancer (by modulating cell signaling and receptor degradation)
05

Safety considerations

Specific safety concerns not documented; general E3 ligase targeting may risk off-target effects on protein turnover and neuronal function
06

Biomarkers

None clearly established for ZNRF1; may have potential as a biomarker in neurodegeneration or inflammatory studies, but not clinically used

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase ZNRF1 (ZNRF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase ZNRF1 (ZNRF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call